Ferrocenyl Azoles: Versatile N-Containing Heterocycles and their Anticancer Activities

The medicinal chemistry of ferrocene has gained its momentum after the discovery of biological activities of ferrocifen and ferroquine. These ferrocenyl drugs have been designed by replacing the aromatic moiety of the organic drugs, tamoxifen and chloroquine respectively, with a ferrocenyl unit. The promising biological activities of these ferrocenyl drugs have paved a path to explore the medicinal applications of several ferrocenyl conjugates. In these conjugates, the ferrocenyl moiety has played a vital role in enhancing or imparting the anticancer activity to the molecule. The ferrocenyl conjugates induce the cytotoxicity by generating reactive oxygen species and thereby damaging the DNA. In medicinal chemistry, the five membered nitrogen heterocycles (azoles) play a significant role due to their rigid ring structure and hydrogen bonding ability with the biomolecules. Several potent drug candidates with azole groups have been in use as chemotherapeutics. Considering the importance of ferrocenyl moiety and azole groups, several ferrocenyl azole conjugates have been synthesized and screened for their biological activities. Hence, in the view of a wide scope in the development of potent drugs based on ferrocenyl azole conjugates, herein we present the details of synthesis and the anticancer activities of ferrocenyl compounds bearing azole groups such as imidazole, triazoles, thiazole and isoxazoles.

Photo-organometallic, Nanoparticle Nucleation on Graphene for Cascaded Doping

Controlling the doping levels in graphene by modifying the electric potential of interfaced nanostructures is important to understand "cascaded-doping"-based applications of graphene. However, graphene does not have active sites for nanoparticle attachment, and covalently adding functional groups on graphene disrupts its planar sp²-hybridization, affecting its cascaded doping. Here we show a hexahepto (η⁶) photo-organometallic chemistry to interface nanoparticles on graphene while retaining the sp²-hybridized state of carbon atoms. For testing cascaded doping with ethanol interaction, transition metal oxide nanoparticles (TMONs) (Cr₂O₃/CrO₃, MoO₃, and WO₃) are attached on graphene. Here, the transition metal forms six σ-bonds and π-back-bonds with the benzenoid rings of graphene, while its opposite face binds to three carbonyl groups, which enable nucleation and growth of TMONs. With a radius size ranging from 50 to 100 nm, the TMONs downshift the Fermi level of graphene (-250 mV; p-doping) via interfacial charge transfer. This is consistent with the blue shift of graphene's G and 2D Raman modes with a hole density of 3.78 × 10¹² cm^-2. With susceptibility to ethanol, Cr_xO₃ nanoparticles on graphene enable cascaded doping from ethanol that adsorbs on Cr_xO₃, leading to doping of graphene to increase the electrical resistance of the TMONs-graphene hybrid. This nanoparticle-on-graphene construct can have several applications in gas/vapor sensing, electrochemical catalysis, and high-energy-density supercapacitors.

Catalytic Asymmetric C-H Arylation of (η6-Arene)Chromium Complexes: Facile Access to Planar-Chiral Phosphines

A catalytic asymmetric direct C-H arylation of (η6-arene)chromium complexes to obtain planar-chiral compounds is reported. The use of the hemilabile ligand H8-BINAP(O) is key to providing high enantioselectivity in this transformation. We show that this methodology opens the door to the synthesis of a variety of planar-chiral chromium derivatives which can be easily transformed into planar chiral mono- or diphosphines. Mechanistic studies, including synthesis and characterization of Pd and Ag complexes and their detection in the reaction mixture, suggest a Pd-catalyzed/Ag-promoted catalytic system where Ag carries out the C-H activation step.

Bio-Organometallic Derivatives of Antibacterial Drugs

Overuse and misuse of antibacterial drugs has resulted in bacteria resistance and in an increase in mortality rates due to bacterial infections. Therefore, there is an imperative necessity of new antibacterial drugs. Bio-organometallic derivatives of antibacterial agents offer an opportunity to discover new active antibacterial drugs. These compounds are well-characterized products and, in several examples, their antibacterial activities have been studied. Both inhibition of the antibacterial activity and strong increase in the antibiotic activity of the parent drug have been found. The synthesis of the main classes of bio-organometallic derivatives of these drugs, as well as examples of the use of structure-activity relation (SAR) studies to increase the activity and to understand the mode of action of bio-organometallic antimicrobial peptides (BOAMPs) and platensimicyn bio-organometallic mimics is presented in this article.

Retained Carrier-Mobility and Enhanced Plasmonic-Photovoltaics of Graphene via ring-centered η6 Functionalization and Nanointerfacing

Binding graphene with auxiliary nanoparticles for plasmonics, photovoltaics, and/or optoelectronics, while retaining the trigonal-planar bonding of sp² hybridized carbons to maintain its carrier-mobility, has remained a challenge. The conventional nanoparticle-incorporation route for graphene is to create nucleation/attachment sites via "carbon-centered" covalent functionalization, which changes the local hybridization of carbon atoms from trigonal-planar sp² to tetrahedral sp³. This disrupts the lattice planarity of graphene, thus dramatically deteriorating its mobility and innate superior properties. Here, we show large-area, vapor-phase, "ring-centered" hexahapto (η⁶) functionalization of graphene to create nucleation-sites for silver nanoparticles (AgNPs) without disrupting its sp² character. This is achieved by the grafting of chromium tricarbonyl [Cr(CO)₃] with all six carbon atoms (sigma-bonding) in the benzenoid ring on graphene to form an (η⁶-graphene)Cr(CO)₃ complex. This nondestructive functionalization preserves the lattice continuum with a retention in charge carrier mobility (9% increase at 10 K); with AgNPs attached on graphene/n-Si solar cells, we report an ∼11-fold plasmonic-enhancement in the power conversion efficiency (1.24%).

Modulating the activity of short arginine-tryptophan containing antibacterial peptides with N-terminal metallocenoyl groups

A series of small synthetic arginine and tryptophan containing peptides was prepared and analyzed for their antibacterial activity. The effect of N-terminal substitution with metallocenoyl groups such as ferrocene (FcCO) and ruthenocene (RcCO) was investigated. Antibacterial activity in different media, growth inhibition, and killing kinetics of the most active peptides were determined. The toxicity of selected derivatives was determined against erythrocytes and three human cancer cell lines. It was shown that the replacement of an N-terminal arginine residue with a metallocenoyl moiety modulates the activity of WRWRW-peptides against Gram-positive and Gram-negative bacteria. MIC values of 2–6 µM for RcCO-W(RW)₂ and 1–11 µM for (RW)₃ were determined. Interestingly, W(RW)₂-peptides derivatized with ferrocene were significantly less active than those derivatized with ruthenocene which have similar structural but different electronic properties, suggesting a major influence of the latter. The high activities observed for the RcCO-W(RW)₂- and (RW)₃-peptides led to an investigation of the origin of activity of these peptides using several important activity-related parameters. Firstly, killing kinetics of the RcCO-W(RW)₂-peptide versus killing kinetics of the (RW)₃ derivative showed faster reduction of the colony forming units for the RcCO-W(RW)₂-peptide, although MIC values indicated higher activity for the (RW)₃-peptide. This was confirmed by growth inhibition studies. Secondly, hemolysis studies revealed that both peptides did not lead to significant destruction of erythrocytes, even up to 500 µg/mL for (RW)₃ and 250 µg/mL for RcCO-W(RW)₂. In addition, toxicity against three human cancer cell lines (HepG2, HT29, MCF7) showed that the (RW)₃-peptide had an IC₅₀ value of ~140 µM and the RcW(RW)₂ one of ~90 µM, indicating a potentially interesting therapeutic window. Both the killing kinetics and growth inhibition studies presented in this work point to a membrane-based mode of action for these two peptides, each having different kinetic parameters.

Small organometallic compounds as antibacterial agents

The emergence of bacterial resistance to commercial antibiotics is an issue of global importance. During the last two decades, the number of antibacterial agents that have been discovered and introduced into the market has steadily declined and failed to meet the challenges posed by rapidly increasing resistance of the pathogens against common antibacterial drugs. The development of new classes of compounds to control the virulence of the pathogens is therefore urgently required. This perspective describes the historical development in brief and recent advances on the preparation of small organometallic compounds as new classes of antibacterial agents with potential for clinical development.